Regulatory News has published 1 story about UpFront Diagnostics on 17 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 17 September 2026.
This page is generated from Regulatory News’ editorial coverage of UpFront Diagnostics. It is not an advertisement.
On the record
- Company
- UpFront Diagnostics (Pockit Diagnostics Ltd)
- Headquarters
- Cambridge, United Kingdom
- Founded
- 2017, Cambridge (as Pockit Diagnostics)
- Regulator
- European Union (In Vitro Diagnostic Regulation)
- Latest milestone
- CE mark (EU IVDR), LVOne stroke test
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
